Cargando…
High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient()
A paediatric patient treated for acute lymphoblastic leukaemia developed cerebral abscesses caused by Aspergillus fumigatus. After surgical draining voriconazole treatment was started. The patient developed a Steven–Johnson syndrome and treatment was switched to L-AmB. The patient developed no new f...
Autores principales: | Brazzola, Pierluigi, Rossi, Mario R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930963/ https://www.ncbi.nlm.nih.gov/pubmed/24567890 http://dx.doi.org/10.1016/j.mmcr.2013.10.003 |
Ejemplares similares
-
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic
Disease: An Update
por: Duckwall, Madison J, et al.
Publicado: (2019) -
Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
por: Feys, Simon, et al.
Publicado: (2023) -
Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis
por: Shirkhani, Khojasteh, et al.
Publicado: (2015) -
Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010) -
Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice
por: Rousseau, Nathalie, et al.
Publicado: (2014)